GLADGladstone Capital

About Gladstone Capital
Gladstone Capital (NASDAQ:GLAD) focuses on providing debt and equity investments to lower middle-market businesses across the United States. They specialize in senior debt, subordinated debt, and equity investments, aiming to support companies in various industries achieve their growth objectives. Their portfolio showcases a diverse range of projects, emphasizing sustainable and profitable growth for their clients. Gladstone Capital's primary objective is to generate attractive returns for its shareholders through income-producing investments while preserving capital. They are committed to building long-term value through strategic investments and partnerships.
What is GLAD known for?
Snapshot
Public US
Ownership
2001
Year founded
73
Employees
McLean, United States
Head office
Loading Map...
Operations
All Locations
United States
Products and/or services of Gladstone Capital
- Debt Financing Solutions - Offering secured loans to lower middle market companies.
- Equity Investments - Providing minority equity co-investments alongside debt financing deals.
- Recurring Revenue Loans - Tailored financing for businesses with predictable, recurring revenue.
- Syndicated Loan Participation - Participating in loan syndications to diversify and enhance portfolio.
- Distributions - Monthly distributions to shareholders, reflecting the company's financial health and performance.
- SBIC Funds Management - Utilizing SBIC funds to provide financing solutions to qualifying small businesses.
Gladstone Capital executive team
- Mr. David John GladstoneFounder, Chairman & CEO
- Mr. Robert L. MarcottePresident
- Ms. Nicole Schaltenbrand CPACFO & Treasurer
- Mr. Michael Bernard LiCalsi Esq., J.D.Chief Administrative Officer, Co-General Counsel & Co-Secretary
- Mr. John Anthony Dellafiora Jr., CPAChief Compliance Officer
- Ms. Paula NovaraHead of Resource Management & Director
- Mr. John SateriManaging Director of Private Finance
- Mr. Christopher J. LeeManaging Director of Private Equity
- Mr. Michael McQuiggExecutive VP & Senior MD
- Mr. Andrew AhlbergManaging Director